Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused…
1,610$
0,63%
Echtzeit-Aktienkurs Minerva Neurosciences Inc.
Bid:
Ask: